ATP5J2 inhibitors represent a specialized class of chemical compounds designed to attenuate the function of ATP5J2, a subunit of the ATP synthase complex. ATP synthase is a critical enzyme involved in the synthesis of adenosine triphosphate (ATP), the primary molecule storing chemical energy in cells. ATP5J2, specifically, is a part of the peripheral stalk of ATP synthase, playing a role in the stabilization of the complex during the rotary catalytic cycle. Inhibitors targeting ATP5J2 are engineered to bind selectively to this subunit, disrupting its normal function and thereby impeding the ATP production process. The inhibition of ATP5J2 can lead to a controlled reduction in ATP synthesis, which is a crucial process for cellular energy distribution and has profound implications on the energetic homeostasis of the cell. By acting on this specific subunit, these inhibitors can exert a finely tuned effect on the ATP synthase complex, a nuance that distinguishes them from broader ATP synthase inhibitors which may affect multiple subunits and lead to more widespread disruptions in energy production.
The biochemical action of ATP5J2 inhibitors involves the direct interaction with the ATP5J2 protein, altering its conformation or its ability to maintain the structural integrity necessary for ATP synthase's function. The specificity of these inhibitors allows for precise targeting, which is advantageous for dissecting the role of ATP5J2 in various cellular processes. As ATP5J2 is involved in the conversion of ADP to ATP, its inhibition leads to an accumulation of ADP and a concomitant decrease in ATP levels. This shift in the balance of adenine nucleotides can have far-reaching effects on cellular metabolism, affecting processes that are energy-dependent. The action of ATP5J2 inhibitors, therefore, extends beyond the direct inhibition of ATP synthesis, potentially influencing various metabolic pathways that are sensitive to changes in cellular energy states. The ability to hinder the function of ATP5J2 selectively ensures that the effects of these inhibitors are precise, allowing for the study of ATP synthase activity and its role within the cell without the confounding effects that may arise from the inhibition of other subunits or energy-producing pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Oligomycin | 1404-19-9 | sc-203342 sc-203342C | 10 mg 1 g | $146.00 $12250.00 | 18 | |
Oligomycin is a macrolide compound that specifically inhibits mitochondrial ATP synthase (Complex V). ATP5J2 is a subunit of this complex; oligomycin binding limits its ability to synthesize ATP, thus inhibiting its function. | ||||||
Bongkrekic acid | 11076-19-0 | sc-205606 | 100 µg | $418.00 | 10 | |
Bongkrekic acid binds to the adenine nucleotide translocase (ANT) in the inner mitochondrial membrane, preventing the exchange of ADP and ATP across the membrane. This indirectly decreases ATP5J2 activity as ANT is essential for supplying the substrates necessary for ATP synthesis. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol has been shown to inhibit ATPase activity of various proteins. By potentially interacting with ATP5J2, it may lead to the inhibition of ATP synthesis due to its ATPase activity modulation. | ||||||
DCC | 538-75-0 | sc-239713 sc-239713A | 25 g 100 g | $71.00 $204.00 | 3 | |
DCCD is a chemical that reacts with carboxyl groups in proteins. It can inhibit ATP synthase by binding to subunits in the complex, which could affect the activity of ATP5J2 by altering its conformation or interaction within the complex. | ||||||
Venturicidin A | 33538-71-5 | sc-202380 sc-202380A | 1 mg 5 mg | $203.00 $465.00 | ||
Venturicidin inhibits ATP synthase by disrupting the proton flow through the F0 sector of the complex. ATP5J2, being part of this complex, would be inhibited as the proton gradient is essential for its activity. | ||||||
Piceatannol | 10083-24-6 | sc-200610 sc-200610A sc-200610B | 1 mg 5 mg 25 mg | $50.00 $70.00 $195.00 | 11 | |
Piceatannol inhibits tyrosine kinases which may indirectly affect ATP5J2 by disrupting signaling pathways that could modulate ATP synthase activity. Although not a direct inhibitor, its influence on cellular energy states can inhibit ATP5J2 function. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $37.00 $77.00 $184.00 $510.00 $1224.00 $5814.00 | 8 | |
Niclosamide uncouples mitochondrial oxidative phosphorylation, which would lead to a decrease in ATP synthesis. As ATP5J2 is part of the ATP synthase complex, its activity would be indirectly inhibited. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $254.00 | 41 | |
Rotenone is an inhibitor of mitochondrial electron transport chain at Complex I. While it does not directly inhibit ATP5J2, it would lead to a reduction in the proton gradient necessary for ATP synthase's activity, thereby indirectly inhibiting ATP5J2. | ||||||
Piericidin A | 2738-64-9 | sc-202287 | 2 mg | $285.00 | 24 | |
Piericidin A is a Complex I inhibitor, similar to rotenone. It would diminish the proton gradient across the mitochondrial membrane required for ATP5J2's activity within the ATP synthase complex. | ||||||